HCV Related Hepatocellular Carcinoma Recurrence After Directly Acting Antivirals: A Randomized Controlled Trial
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Hepatitis C
- Hepatocellular Carcinoma
- Neoplasm Recurrence
- Treatment Complication
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Other
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04653818
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Ahmed Kamal, MD, PhD Lecturer of Internal Medicine and Hepatology, Faculty of Medicine, Alexandria University
Get Well Soon